These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20363583)

  • 1. Can we defer/omit a type and screen blood test for pregnant women who know their blood type?
    Shah KH; Cavallo E; Paisley J; Kurobe A; Newman DH
    J Emerg Med; 2011 Aug; 41(2):223-7. PubMed ID: 20363583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance in appropriate Rh testing and treatment with Rh immunoglobulin in the emergency department.
    Griffey RT; Chen BC; Krehbiel NW
    Ann Emerg Med; 2012 Apr; 59(4):285-93. PubMed ID: 22153971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of ABO and Rhesus blood groups in District Swat, Pakistan.
    Khattak ID; Khan TM; Khan P; Shah SM; Khattak ST; Ali A
    J Ayub Med Coll Abbottabad; 2008; 20(4):127-9. PubMed ID: 19999224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the clinical utility of routine antenatal screening of pregnant women at first clinic attendance for haemoglobin genotypes, haematocrit, ABO and Rh blood groups in Port Harcourt, Nigeria.
    Jeremiah ZA
    Afr J Reprod Health; 2005 Dec; 9(3):112-7. PubMed ID: 16623195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion in bimaxillary orthognathic operations: need for testing of type and screen.
    Fenner M; Kessler P; Holst S; Nkenke E; Neukam FW; Holst AI
    Br J Oral Maxillofac Surg; 2009 Dec; 47(8):612-5. PubMed ID: 19608311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a third-trimester antibody screen in Rh+ women necessary?
    Rothenberg JM; Weirermiller B; Dirig K; Hurd WW; Schilder J; Golichowski A
    Am J Manag Care; 1999 Sep; 5(9):1145-50. PubMed ID: 10621080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of positive antibody screens at delivery in Rh-negative parturients.
    Cambic CR; Scavone BM; McCarthy RJ; Eisenberg P; Sanchez EM; Sullivan JT; Wong CA
    Can J Anaesth; 2010 Sep; 57(9):811-6. PubMed ID: 20661682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is antibody screening in Rh (D)-positive pregnant women necessary?
    Lurie S; Eliezer E; Piper I; Woliovitch I
    J Matern Fetal Neonatal Med; 2003 Dec; 14(6):404-6. PubMed ID: 15061320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal RhD genotyping by maternal serum analysis: a two-year experience.
    Gautier E; Benachi A; Giovangrandi Y; Ernault P; Olivi M; Gaillon T; Costa JM
    Am J Obstet Gynecol; 2005 Mar; 192(3):666-9. PubMed ID: 15746656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suitability of hemolyzed specimens for compatibility testing using automated technology.
    Laga A; Cheves T; Maroto S; Coutts M; Sweeney J
    Transfusion; 2008 Aug; 48(8):1713-20. PubMed ID: 18482191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization].
    Mannessier L
    Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood ordering in obstetrics and gynecology: recommendations for the type and screen.
    Hill ST; Lavin JP
    Obstet Gynecol; 1983 Aug; 62(2):236-40. PubMed ID: 6408546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rhesus (Rh(D)) negative frequency and ethnic-group based ABO blood group distribution in Ethiopia.
    Golassa L; Tsegaye A; Erko B; Mamo H
    BMC Res Notes; 2017 Jul; 10(1):330. PubMed ID: 28747227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of fetal cell sorting to determine prenatally fetal E/e or e/e Rh genotype from peripheral maternal blood.
    Geifman-Holtzman O; Makhlouf F; Kaufman L; Gonchoroff NJ; Holtzman EJ
    Am J Obstet Gynecol; 2000 Aug; 183(2):462-8. PubMed ID: 10942488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester screening for Down syndrome in rhesus negative women.
    Muhcu M; Mungen E; Atay V; Ipcioglu OM; Dundar O; Ergur R; Yergok YZ
    Prenat Diagn; 2008 May; 28(5):404-7. PubMed ID: 18318000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the accuracy of a rapid point-of-care test for determining Rh(D) phenotype.
    Herold TJ; Whittaker DS; Glynn T
    Acad Emerg Med; 2005 May; 12(5):474-6. PubMed ID: 15860702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of an emergency medical services-administered alternative transport protocol.
    Knapp BJ; Tsuchitani SN; Sheele JM; Prince J; Powers J
    Prehosp Emerg Care; 2009; 13(4):432-6. PubMed ID: 19731153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency contraception: what do our patients know?
    Abbott J; Feldhaus KM; Houry D; Lowenstein SR
    Ann Emerg Med; 2004 Mar; 43(3):376-81. PubMed ID: 14985666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transvaginal bleeding in pregnancy, as risk factor of Rhesus-D antigen isoimmunization].
    Hernández-Andrade E; Ahued-Ahued JR
    Salud Publica Mex; 2003; 45(6):492-6. PubMed ID: 14974293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.